Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cytrx Corp
(OP:
CYTR
)
N/A
UNCHANGED
Last Price
Updated: 1:53 PM EDT, Oct 5, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.0920
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
LadRx Corporation Announces OTCQB Ticker Change to LADX
October 05, 2022
From
LadRx Corporation
Via
Business Wire
CytRx Corporation Relaunches as LadRx Corporation
September 23, 2022
From
CytRx Corporation
Via
Business Wire
Performance
More News
Read More
European Patent Office Awards CytRx Key Patent
September 07, 2022
From
CytRx Corporation
Via
Business Wire
CytRx Welcomes Cary J. Claiborne to the CytRx Board of Directors
August 09, 2022
From
CytRx Corporation
Via
Business Wire
CytRx Announces Distribution of Series D Preferred Stock to Holders of Its Common Stock
May 19, 2022
From
CYTRX CORPORATION
Via
Business Wire
CytRx Highlights Strategic Purchase of Arimoclomol by KemPharm, Inc.
May 17, 2022
From
CytRx Corporation
Via
Business Wire
CytRx Partners with Oncology Development Expert to Advance LADR Platform
April 20, 2022
From
CytRx Corporation
Via
Business Wire
CytRx Issues Open Letter to Stockholders Regarding Recent Corporate Progress
March 21, 2022
From
CytRx Corporation
Via
Business Wire
Orphazyme Calls For Court-Mediated Restructuring, Lays Off 50% Workforce
March 11, 2022
Via
Benzinga
CytRx Comments on Orphazyme's Update on European Union Regulatory Review of Arimoclomol in Niemann-Pick Disease Type C
February 24, 2022
From
CytRx Corporation
Via
Business Wire
CytRx Highlights Orphazyme's Update on Planned NDA Resubmission for Arimoclomol in Niemann-Pick Disease Type C
February 14, 2022
From
CytRx Corporation
Via
Business Wire
CytRx to Hold Town Hall for Stockholders on Thursday, January 20th
January 18, 2022
From
CytRx Corporation
Via
Business Wire
CytRx to Participate in the H.C. Wainwright BioConnect Virtual Conference
January 07, 2022
From
CytRx Corporation
Via
Business Wire
CytRx Announces the Appointment of Dr. Stephen Snowdy as Chief Executive Officer
January 03, 2022
From
CytRx Corporation
Via
Business Wire
CytRx Highlights ImmunityBio's Use of Aldoxorubicin in Ongoing Clinical Studies for Various Forms of Cancer
December 21, 2021
From
CytRx Corporation
Via
Business Wire
CytRx Provides a Bold Vision on Centurion BioPharma's Plans for a State-of-the-Art Cancer Center in Las Vegas, Nevada
November 30, 2021
From
CytRx Corporation
Via
Business Wire
CytRx Comments on Quarterly Results and Recent Strategic Initiatives
November 12, 2021
From
CytRx Corporation
Via
Business Wire
CytRx Announces Centurion BioPharma Has Been Invited to Present Plans for a State-of-the-Art Cancer Center in Las Vegas, Nevada
November 09, 2021
From
CytRx Corporation
Via
Business Wire
CytRx Highlights Orphazyme's Update on Productive Meeting with FDA Regarding Arimoclomol in Niemann-Pick Disease Type C
November 02, 2021
From
CytRx Corporation
Via
Business Wire
CytRx Highlights ImmunityBio's Completion of Enrollment in Phase 2 Study of Advanced Metastatic Pancreatic Cancer Treatment
October 14, 2021
From
CytRx Corporation
Via
Business Wire
CytRx to Present at Upcoming Virtual LD Micro Conference
October 05, 2021
From
CytRx Corporation
Via
Business Wire
CytRx to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 08, 2021
From
CytRx Corporation
Via
Business Wire
CytRx Highlights Orphazyme’s Published Results From Its Phase 2/3 Trial of Arimoclomol in Niemann-Pick Disease Type C
August 24, 2021
From
CytRx Corporation
Via
Business Wire
CytRx Comments on Quarterly Results and Recent Strategic Initiatives
August 12, 2021
From
CytRx Corporation
Via
Business Wire
CytRx Announces Director Election Results from 2021 Annual Meeting of Stockholders
July 29, 2021
From
CytRx Corporation
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.